Leveraging FDA Guidance on CFL to Demonstrate Value of FDA Cleared Devices

Harnessing real-world data to demonstrate long-term effectiveness, safety, product differentiation and actionable strategies for stakeholders
Highlighting patient outcomes, economic impact, and innovation to support market access
Enhancing stakeholder engagement through value-driven messaging for prescribers, patients, payers, and policymakers to drive adoption
Regulatory compliance and market access through aligning regulatory requirements with commercial strategy to optimize positioning and ensure compliance